| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 89.942 | 74 |
| GSM780708 | Untreated after 4 days (C2_1) | 105.846 | 76 |
| GSM780709 | Untreated after 4 days (C3_1) | 118.989 | 78 |
| GSM780719 | Untreated after 4 days (C1_2) | 85.8178 | 73 |
| GSM780720 | Untreated after 4 days (C2_2) | 105.846 | 76 |
| GSM780721 | Untreated after 4 days (C3_2) | 117.143 | 77 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 105.546 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 83.4996 | 72 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 92.4447 | 74 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 110.902 | 77 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 98.9165 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 96.9975 | 75 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 97.9459 | 75 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 104.797 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 80.869 | 72 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 91.1324 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 108.445 | 76 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 97.8323 | 75 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 109.545 | 76 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 105.816 | 76 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 101.554 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 104.214 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 104.711 | 76 |